# AE Tables and Plots

| Adverse Event | US Count of AE reports post Vaccine | US Rate of reported AE<br/>(count/Month) | US Rate of reported AE<br/>(count/billion doses) | US Rate of reported AE<br/>(count/billion people vaccinated) |
| --- | --: | --: | --: | --: |
| Menstrual abnormality | 6352<br/>54 | 353<br/>0.184 | 10700<br/>16.4 | 24400<br/>173 |
| Miscarriage | 1232<br/>259 | 68.4<br/>0.881 | 2070<br/>78.5 | 4740<br/>827 |
| Fetal chromosomal abnormalities | 7<br/>0 | 0.389<br/>0.00 | 11.7<br/>0.00 | 26.9<br/>0.00 |
| Fetal malformation | 2<br/>1 | 0.111<br/>0.00340 | 3.35<br/>0.303 | 7.69<br/>3.19 |
| Fetal cystic hygroma | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal cardiac disorders | 10<br/>2 | 0.556<br/>0.00680 | 16.8<br/>0.606 | 38.5<br/>6.39 |
| Fetal arrhythmia | 3<br/>0 | 0.167<br/>0.00 | 5.03<br/>0.00 | 11.5<br/>0.00 |
| Fetal cardiac arrest | 3<br/>0 | 0.167<br/>0.00 | 5.03<br/>0.00 | 11.5<br/>0.00 |
| Fetal vascular mal-perfusion | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal growth abnormalities | 59<br/>20 | 3.28<br/>0.0680 | 99.0<br/>6.06 | 227<br/>63.9 |
| Fetal abnormal surveillance | 125<br/>36 | 6.94<br/>0.122 | 210<br/>10.9 | 481<br/>115 |
| Fetal placental thrombosis | 5<br/>0 | 0.278<br/>0.00 | 8.39<br/>0.00 | 19.2<br/>0.00 |
| Fetal stillbirth | 168<br/>42 | 9.33<br/>0.143 | 282<br/>12.7 | 646<br/>134 |
| Low amniotic fluid | 11<br/>1 | 0.611<br/>0.00340 | 18.4<br/>0.303 | 42.3<br/>3.19 |


| Adverse Event | Global Count of AE reports post Vaccine | Global Rate of reported AE<br/>(count/Month) | Global Rate of reported AE<br/>(count/billion doses) | Global Rate of reported AE<br/>(count/billion people vaccinated) |
| --- | --: | --: | --: | --: |
| Menstrual abnormality | 12843<br/>65 | 714<br/>0.221 | 1060<br/>0.985 | 2460<br/>8.43 |
| Miscarriage | 3338<br/>325 | 185<br/>1.11 | 277<br/>4.92 | 638<br/>42.2 |
| Fetal chromosomal abnormalities | 10<br/>0 | 0.556<br/>0.00 | 0.829<br/>0.00 | 1.91<br/>0.00 |
| Fetal malformation | 22<br/>2 | 1.22<br/>0.00680 | 1.82<br/>0.0303 | 4.21<br/>0.259 |
| Fetal cystic hygroma | 8<br/>0 | 0.444<br/>0.00 | 0.663<br/>0.00 | 1.53<br/>0.00 |
| Fetal cardiac disorders | 18<br/>2 | 1.00<br/>0.00680 | 1.49<br/>0.0303 | 3.44<br/>0.259 |
| Fetal arrhythmia | 5<br/>0 | 0.278<br/>0.00 | 0.414<br/>0.00 | 0.956<br/>0.00 |
| Fetal cardiac arrest | 20<br/>0 | 1.11<br/>0.00 | 1.66<br/>0.00 | 3.82<br/>0.00 |
| Fetal vascular mal-perfusion | 12<br/>0 | 0.667<br/>0.00 | 0.994<br/>0.00 | 2.29<br/>0.00 |
| Fetal growth abnormalities | 188<br/>24 | 10.4<br/>0.0816 | 15.6<br/>0.364 | 35.9<br/>3.11 |
| Fetal abnormal surveillance | 178<br/>45 | 9.89<br/>0.153 | 14.7<br/>0.682 | 34.0<br/>5.84 |
| Fetal placental thrombosis | 6<br/>0 | 0.333<br/>0.00 | 0.497<br/>0.00 | 1.15<br/>0.00 |
| Fetal stillbirth | 402<br/>64 | 22.3<br/>0.218 | 33.3<br/>0.970 | 76.9<br/>8.30 |
| Low amniotic fluid | 17<br/>1 | 0.944<br/>0.00340 | 1.41<br/>0.0152 | 3.25<br/>0.130 |


| Adverse Event | Relative Rate<br/>(by time) | Relative Rate<br/>(by dose) | Relative Rate<br/>(by person vaccinated) |
| --- | --: | --: | --: |
| Menstrual abnormality | 4256.6 [1589.1-12893] p=0.0 <br/>2523.5 [894.57-6419.0] p=0.0| 1191.9 [673.95-2162.8] p=0.0<br/>738.1 [391.6-1584] p=0.0| 298.1 [223.0-406.0] p=0.0<br/>144.9 [108.6-197.4] p=0.0|
| Miscarriage | 177.1 [114.4-283.5] p=0.0 <br/>83.4 [50.8-143] p=0.0| 57.1 [44.3-74.7] p=0.0<br/>26.9 [20.2-36.5] p=0.0| 15.2 [13.3-17.5] p=0.0<br/>5.8 [5.0-6.7] p=0.0|
| Fetal chromosomal abnormalities |  p=0.00058 <br/> p=0.0048|  p=0.00058<br/> p=0.0048|  p=0.00058<br/> p=0.0048|
| Fetal malformation | 21.3 [10.0-32.0] p=1.9x10^-07^ <br/>2.0 [0.0-5.0] p=0.20| 20.0 [7.67-31.0] p=1.9x10^-07^<br/>1.9 [0.0-5.0] p=0.20| 15.3 [4.50-30.0] p=2.1x10^-06^<br/>1.6 [0.0-5.0] p=0.20|
| Fetal cystic hygroma |  p=0.0024 <br/> p=0.020|  p=0.0024<br/> p=0.020|  p=0.0024<br/> p=0.020|
| Fetal cardiac disorders | 17.5 [8.00-27.0] p=2.6x10^-06^ <br/>9.70 [4.00-17.0] p=0.00058| 16.4 [6.00-26.0] p=2.6x10^-06^<br/>9.1 [3.0-16] p=0.00058| 12.5 [3.60-25.0] p=2.7x10^-05^<br/>6.4 [1.5-15] p=0.0047|
| Fetal arrhythmia |  p=0.020 <br/> p=0.088|  p=0.020<br/> p=0.088|  p=0.020<br/> p=0.088|
| Fetal cardiac arrest |  p=6.9x10^-07^ <br/> p=0.088|  p=6.9x10^-07^<br/> p=0.088|  p=6.9x10^-07^<br/> p=0.088|
| Fetal vascular mal-perfusion |  p=0.00015 <br/> p=0.020|  p=0.00015<br/> p=0.020|  p=0.00015<br/> p=0.020|
| Fetal growth abnormalities | 126.3 [42.00-210.0] p=0.0 <br/>42.5 [14.0-72.0] p=0.0| 56.2 [20.7-189] p=0.0<br/>21.6 [7.14-64.0] p=0.0| 12.4 [7.42-21.4] p=0.0<br/>3.8 [2.2-6.8] p=3.2x10^-07^|
| Fetal abnormal surveillance | 82.6 [26.9-193] p=0.0 <br/>68.0 [21.6-140] p=0.0| 25.3 [12.2-58.7] p=0.0<br/>23.6 [10.1-63.0] p=0.0| 6.0 [4.1-9.0] p=0.0<br/>4.3 [2.9-6.6] p=0.0|
| Fetal placental thrombosis |  p=0.0096 <br/> p=0.020|  p=0.0096<br/> p=0.020|  p=0.0096<br/> p=0.020|
| Fetal stillbirth | 135.3 [48.25-412.0] p=0.0 <br/>82.2 [26.5-184] p=0.0| 38.0 [21.1-73.0] p=0.0<br/>26.3 [12.2-60.0] p=0.0| 9.5 [6.9-13] p=0.0<br/>5.0 [3.4-7.2] p=0.0|
| Low amniotic fluid | 16.8 [8.00-25.0] p=5.1x10^-06^ <br/>10.9 [5.00-18.0] p=0.00029| 16.2 [7.00-25.0] p=5.1x10^-06^<br/>10.5 [4.00-18.0] p=0.00029| 14.2 [4.67-25.0] p=5.1x10^-06^<br/>8.8 [2.5-17] p=0.00029|





![forest-Dose (Global)](forest-Dose%20(Global).png)

![forest-Dose (US)](forest-Dose%20(US).png)

![forest-Month (Global)](forest-Month%20(Global).png)

![forest-Month (US)](forest-Month%20(US).png)

![forest-People (Global)](forest-People%20(Global).png)

![forest-People (US)](forest-People%20(US).png)

